Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 19-25 , 15 September 2002

Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging

  • John S Meyer

      Affiliations

    • Corresponding Author InformationCorresponding author. Cerebrovascular Research Laboratory, Veterans Administration Medical Center, Building 110, Room 225, 2002 Holcombe Boulevard, 151A, Houston, TX 77030, USA. Tel.: +1-713-795-5807; fax: +1-713-794-7583
    • Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    • Cerebrovascular Research Laboratory, Veterans Administration Medical Center, Houston, TX, USA
    • ,
  • Gelin Xu

      Affiliations

    • Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    • Cerebrovascular Research Laboratory, Veterans Administration Medical Center, Houston, TX, USA
    • ,
  • John Thornby

      Affiliations

    • Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA
    • Biostatistical Laboratory, Veterans Administration Medical Center, Houston, TX, USA
    • ,
  • Munir Chowdhury

      Affiliations

    • Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    • Cerebrovascular Research Laboratory, Veterans Administration Medical Center, Houston, TX, USA
    • ,
  • Minh Quach

      Affiliations

    • Department of Neurology, Baylor College of Medicine, Houston, TX, USA
    • Cerebrovascular Research Laboratory, Veterans Administration Medical Center, Houston, TX, USA

Received 20 February 2002 ,Revised 20 May 2002 ,Accepted 21 May 2002.

References 

  1. Ritchie K, Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000;355:225–228
  2. Almkvist O, Basun H, Backman L, Herlitz A, Lannfelt L, Small B, et al.  Mild cognitive impairment—an early stage of Alzheimer's disease?. J. Neural Transm., Suppl. 1998;54:21–29
  3. Kral VA. Senescent forgetfulness: benign and malignant. CMAJ, Can. Med. Assoc. J. 1962;86:257–260
  4. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change. Report of a National Institute of Mental Health Work Group. Dev. Neuropsychol. 1986;2:261–276
  5. Levy R. Aging-associated cognitive decline. Int. Psychogeriatr. 1994;6:63–68
  6. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 1997;349:1793–1796
  7. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133–1142
  8. Rockwood K, Howard K, MacKnight C, Darvesh S. Spectrum of disease in vascular cognitive impairment. Neuroepidemiology. 1999;18:248–254
  9. Rockwood K. Vascular cognitive impairment in clinical practice. Presented in the Second International Congress on Vascular Dementia. J. Neurol. Sci. 2002; in press
  10. Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, et al.  Volumes of medial temporal lobe structures in patients with Alzheimer's disease and mild cognitive impairment (and in healthy controls). Biol. Psychiatry. 1998;43:60–68
  11. Tierney MC, Szalai JP, Snow WG, Fisher RH. The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. Arch. Neurol. 1996;53:423–427
  12. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999;56:303–308
  13. Black SE. Can SPECT predict the future for mild cognitive impairments?. J. Neurol. Sci. 1999;26:23–28
  14. Dunn NR, Pearce GL, Shakir SA. Adverse effects associated with the use of donepezil in general practice in England. J. Psychopharmacol. 2000;14:406–408
  15. Li YS, Meyer JS, Haque AH, Chowdhury MH, Hinh P, Quach M. Feasibility of vascular dementia treatment with cholinesterase inhibitors. Int. J. Geriatr. Psychiatry. 2002;17:193–196
  16. Meyer JS, Li YS, Xu G, Thornby J, Chowdhury M, Quach M. Feasibility of treatment of mild cognitive impairment with cholinesterase inhibitors. Int. J. Geriatr. Psychiatry. 2002;17:1–3
  17. Flicker C, Ferris SH, Reisber B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41:1006–1009
  18. Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch. Neurol. 2001;58:411–416
  19. Kluger A, Gianutsos JG, Golomb J, Ferris SH, Reisberg B. Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimer's disease: diagnostic and differential diagnostic features. Int. Psychogeriatr. 1997;9:307–316
  20. Wang QS, Zhou JN. Retrieval and encoding of episodic memory in normal aging and patients with mild cognitive impairment. Brain Res. 2002;924:113–115
  21. Wolf H, Grunwald M, Ecke GM, Zedlick D, Bettin S, Dannenberg C, et al.  The prognosis of mild cognitive impairment in the elderly. J. Neural Transm., Suppl. 1998;54:31–50
  22. Perry RJ, Watson P, Hodges JR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia. 2000;38:252–271
  23. Lines CR, Dawson C, Preston GC, Reich S, Foster C, Traub M. Memory and attention in patients with senile dementia of the Alzheimer type and in normal elderly subjects. J. Clin. Exp. Neuropsychol. 1991;13:691–702
  24. Meyer JS, Rauch GM, Crawford K, Rauch RA, Konno S, Akiyama H, et al.  Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int. J. Geriatr. Psychiatry. 1999;14:1050–1061
  25. Folstein MF, Folstein SE, McHugh PP. “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12:189–198
  26. Jacobs JW, Bernhard MR, Delgado A, Strain JJ. Screening for organic mental syndromes in the medically ill. Ann. Intern. Med. 1977;86:40–46
  27. Hamilton MA. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  28. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269:2386–2391
  29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939–944
  30. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al.  Vascular dementia: diagnostic criteria for research studies. Report of the NINCDS–AIREN International Workshop. Neurology. 1993;43:250–260
  31. Fitz AG, Teri L. Depression, cognition, and functional ability in patients with Alzheimer's disease. J. Am. Geriatr. Soc. 1994;42:186–191
  32. Cummings JL, Miller B, Hill MA, Neshkes R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer's type. Arch. Neurol. 1987;44:388–389
  33. Li YS, Meyer JS, Thornby J. Longitudinal follow-up of depressive symptoms among normal versus cognitively impaired elderly. Int. J. Geriatr. Psychiatry. 2001;16:718–727
  34. Ganguli M, Ratcliff G, Huff FJ, Belle S, Kancel MJ, Fischer L, et al.  Serial sevens versus world backwards: a comparison of the two measures of attention from the MMSE. J. Geriatr. Psychiatry Neurol. 1990;3:203–207
  35. Geerlings MI, Schmand B, Jonker C, Lindeboom J, Bouter LM. Education and incident Alzheimer's disease: a biased association due to selective attrition and use of a two-step diagnostic procedure?. Int. J. Epidemiol. 1999;28:492–497
  36. Katzman R. Apolipoprotein E and Alzheimer's disease. Curr. Opin. Neurobiol. 1994;4:703–707
  37. Salmon DP, Bondi MW. Neuropsychology of Alzheimer's disease. In:  Terry RD,  Katzman R,  Bick KL,  Sisodia SS editor. Alzheimer's disease. 2nd ed.. Philadelphia: Lippincott Williams & Wilkins; 1999;p. 39–56
  38. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al.  Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol. 2001;58:397–405
  39. Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ. Establishing the limits of the Mini-Mental State Examination of “subtests”. Arch. Neurol. 1992;49:87–92
  40. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, et al.  Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 2002;443:136–153
  41. Perry RJ, Watson P, Hodges JR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia. 2000;38:252–271
  42. Pappas BA, Bayley PJ, Bui BK, Hansen LA, Thal LJ. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients. Neurobiol. Aging. 2000;21:11–17
  43. Voytko ML. Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?. Behav. Brain Res. 1996;75:13–25
  44. Small BJ, Fratiglioni L, Vitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease, three and six year follow-up of a population-based sample. Arch. Neurol. 2000;57:839–844
  45. Cahill L, McGaugh JL, Weinberger NM. The neurobiology of learning and memory: some reminders to remember. Trends Neurosci. 2001;24:578–591
  46. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J. Am. Geriatr. Soc. 1992;40:922–935
  47. Doody RS, Massman P, Dunn JK. A method for estimating progression rates in Alzheimer disease. Arch. Neurol. 2001;58:449–454
  48. Meyer JS, Judd BW, Tawaklna T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia. JAMA. 1986;250:2203–2209
  49. Meyer JS, Obara K, Muramatsu K, Mortel KF, Shirai T. Cognitive performance after small strokes correlates with ischemia not atrophy of the brain. Dementia. 1995;6:312–322
  50. Meyer JS, Akiyama H, Shirai T. Cerebral CT changes correlate with cognitive declines and identify dementia of Alzheimer's type in Alzheimer disease. In:  Ballas P editors. Facts, research and interventions in gerontology. Serdi, Ausoville, Tologone, France: Serdi Publishing; 1996;p. 28–38
  51. Meyer JS, Rauch GM, Rauch RA, Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol. Aging. 2000;21:161–169
  52. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann. N.Y. Acad. Sci. 2000;903:411–423
  53. Sparks DL, Martin TA, Gross DR, Hunsaker JC. Link between heart disease, cholesterol, and Alzheimer's disease: a review. Microsc. Res. Tech. 2000;50:287–290
  54. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al.  Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–1451
  55. Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia. Age-dependent incidence, prevalence, and mortality in the old. Arch. Intern. Med. 1991;151:989–992
  56. Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JT. Limitations of the Mini-Mental State Examination in diagnosing dementia in general practice. Int. J. Geriatr. Psychiatry. 1997;12:101–108
  57. Benedict RH, Brandt J. Limitation of the Mini-Mental State Examination for the detection of amnesia. J. Geriatr. Psychiatry Neurol. 1992;5:233–237
  58. Dick JP, Guiloff RJ, Stewart A, Blackstock J, Bielawska C, Paul EA, et al.  Mini-Mental State Examination in neurological patients. J. Neurol. Neurosurg. Psychiatry. 1987;47:496–499
  59. Schwamm LH, Van Dyke C, Kiernan RJ, Merrin EL, Mueller J. The Neurobehavioral Cognitive Status Examination: comparison with the Cognitive Capacity Screening Examination and the Mini-Mental State Examination in a neurosurgical population. Ann. Intern. Med. 1987;107:486–491
  60. Espinoza R. Limitations of MMSE when screening for dementia. Geriatrics. 2001;56:14
  61. Mazzoni M, Ferroni L, Lombardi L, Del Torto E, Vista M, Moretti P. Mini-Mental State Examination (MMSE): sensitivity in an Italian sample of patients with dementia. Ital. J. Neurol. Sci. 1992;13:323–329
  62. Zaudig M. A new systematic method of measurement and diagnosis of “mild cognitive impairment” and dementia according to ICD-10 and DSM-III-R criteria. Int. Psychogeriatr., Suppl. 1992;4:203–219

PII: S0022-510X(02)00159-4

Journal of the Neurological Sciences
Volume 201, Issue 1 , Pages 19-25 , 15 September 2002

Article Tools

* Image Usage & Resolution